Leukapheresis Product market volume is expected to reach USD 27.1 billion in the next 10 years with a CAGR of 7.8%. The Leukapheresis Products Market is significantly influenced by many market factors which drive the market dynamics and determine the development pathway of the market. One of the major factors fuelling the growth of this market has been the increased prevalence of leukemia and other blood related illnesses. With population growing rapidly and aging at the same time, the occurrence of such diseases has significantly increased compared to before, making advanced therapeutic interventions like leukapheresis necessary. Additionally, the rising awareness and early diagnosis of blood disorders contribute greatly to the upsurge of demand for leukapheresis products.
Technology is one of the main factors that influence the development of the market environment. The leukapheresis products keep on innovating, which has resulted in the manufacture of more efficacious and user friendly devices, and hence, better patient experience and treatment outcomes. The incorporation of automation and development of advanced devices has not only increased the effectiveness of leukapheresis procedures but at the same time has made the healthcare streamline, which has led to the market expansion.
Another key element influencing the Leukapheresis Products Industry involves the regulatory environment. Strict regulatory frameworks and compliance standards dictated by health authorities worldwide shape the regulation and marketing of such products. Manufacturers in the leukapheresis industry need to comply with the strictest rules of the regulatory authorities in order to guarantee the safety and efficacy of their products before entering the market. These regulations are at the same time a challenge and an opportunity, as companies that manage the compliance environment will gain a competitive edge.
The rivalry and participation of key actors has a profound impact on the structure of the leukapheresis market. The existing companies with greatly established market share and participation of new entrants and startups trigger competition and innovation. Collaborations, partnerships and mergers within the industry are the strategies used by companies to strengthen their market position and expand their product line.
Also, regional economic structures and healthcare expenditure help the leukapheresis products market expand. Developed nations with strong medical facilities as a rule follow the trend for higher adoption rates of the advanced medical technology, including leukapheresis products. On the other hand, the speed of uptake might be restricted for developing countries because of the financial issues and limited healthcare resources they have at their disposal. Markets players mostly adapt their strategies depending on the regional economic conditions seeking to take advantage of growing opportunities.
Segmentation:
The leukapheresis products market has been segmented into type, application, and end user. On the basis of type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.
The market, on the basis of application, has been segmented into research applications and therapeutic applications.
On the basis of end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The leukapheresis products market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European leukapheresis products market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The leukapheresis products market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The leukapheresis products market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players:
Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, StemExpress and others are some of the key players in the leukapheresis products market.
Regional Market Summary: Global Leukapheresis Products Market Share (%), by Region, 2017
Source: America’s Blood Centers, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the leukapheresis products market owing to the growing number of blood donations, rising incidence and prevalence of leukaemia and growing demand for leukopaks in clinical research. According to the America’s Blood Centers, more than 15 million pints of blood are transfused in the US each year.
Europe is expected to hold the second largest position in the leukapheresis products market. The market growth in this region is attributed to the increasing prevalence of leukemia and well-developed healthcare sector in the region. According to the Cancer Research UK, about 9,900 new cases of leukaemia were reported in UK in 2015.
The leukapheresis products market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major multinational pharma and biotech companies, and improvement in healthcare access.
The Middle East & Africa has the lowest share of the leukapheresis products market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Recent Development
Leukapheresis Products Market, by Type
Leukapheresis Products Market, by Application
Leukapheresis Products Market, by End User
Leukapheresis Products Market, by Region
Leukapheresis Products Market, by Key Players
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)